Xiaojian Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaojian Fu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Bo Xu
Center for Obesity and Hernia Surgery, Department of General Surgery, Huashan Hospital, Shanghai, China
3 shared publications - Qiwei Shen
Center for Obesity and Hernia Surgery, Department of General Surgery, Huashan Hospital, Shanghai, China
3 shared publications - Rong Hua
Center for Obesity and Hernia Surgery, Department of General Surgery, Huashan Hospital, Shanghai, China
3 shared publications - Yikai Shao
Center for Obesity and Hernia Surgery, Department of General Surgery, Huashan Hospital, Shanghai, China
3 shared publications - Chong Cao
Center for Obesity and Hernia Surgery, Department of General Surgery, Huashan Hospital, Shanghai, China
2 shared publications - Mengcheng He
Center for Obesity and Hernia Surgery, Department of General Surgery, Huashan Hospital, Shanghai, China
2 shared publications
Latest Publications
- 31 August 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5145-5153
Weight Loss Threshold and Inflection Points for Biochemical Remission of Male Obesity-Associated Secondary Hypogonadism After Sleeve Gastrectomy
- 31 August 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5145-5153
Weight Loss Threshold and Inflection Points for Biochemical Remission of Male Obesity-Associated Secondary Hypogonadism After Sleeve Gastrectomy
- 31 October 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (12) , 5288-5297
Baseline Risk Factors and Predictive Nomogram for Short-Term Persistent Hyperuricemia Following Laparoscopic Sleeve Gastrectomy: A Dual Center Study
Introduction Although laparoscopic sleeve gastrectomy (LSG) effectively addresses obesity, its outcomes on hyperuricemia (HUA) remission remain inconsistent. We aimed to identify baseline predictors and develop a nomogram for HUA persistence six months following LSG. Methods We retrospectively analyzed patients with obesity and HUA undergoing primary LSG at Huashan Hospital. An independent validation cohort from the Affiliated Hospital of Xuzhou Medical University was included. Clinical data, including demographics, anthropometric measurements, and biochemical markers were analyzed. Logistic regression analyses identified independent predictors of persistent HUA, and a predictive nomogram was developed and externally validated. Results A total of 631 patients was enrolled in this study. Persistent HUA was observed in 41.8% (159/380) of patients in the training cohort. Multivariate analysis identified male sex (OR = 4.97, 95% CI: 2.35–10.51, P < 0.001), waist circumference (WC; OR = 1.06, 95% CI: 1.02–1.10, P = 0.006), and baseline UA levels (OR = 1.01, 95% CI: 1.01–1.02, P < 0.001) as significant predictors. The nomogram demonstrated excellent discriminative ability (AUC = 0.85, 95% CI: 0.82–0.86) and calibration. In the validation cohort, persistent HUA was observed in 35.5% (89/251), and the nomogram maintained robust predictive performance (AUC = 0.81, 95% CI: 0.76–0.82). Conclusion Male sex, increased WC, and elevated baseline UA predict postoperative persistent HUA. The nomogram provides a practical clinical tool for predicting short-term HUA non-remission post-LSG.
- 31 October 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (12) , 5288-5297
Baseline Risk Factors and Predictive Nomogram for Short-Term Persistent Hyperuricemia Following Laparoscopic Sleeve Gastrectomy: A Dual Center Study
Introduction Although laparoscopic sleeve gastrectomy (LSG) effectively addresses obesity, its outcomes on hyperuricemia (HUA) remission remain inconsistent. We aimed to identify baseline predictors and develop a nomogram for HUA persistence six months following LSG. Methods We retrospectively analyzed patients with obesity and HUA undergoing primary LSG at Huashan Hospital. An independent validation cohort from the Affiliated Hospital of Xuzhou Medical University was included. Clinical data, including demographics, anthropometric measurements, and biochemical markers were analyzed. Logistic regression analyses identified independent predictors of persistent HUA, and a predictive nomogram was developed and externally validated. Results A total of 631 patients was enrolled in this study. Persistent HUA was observed in 41.8% (159/380) of patients in the training cohort. Multivariate analysis identified male sex (OR = 4.97, 95% CI: 2.35–10.51, P < 0.001), waist circumference (WC; OR = 1.06, 95% CI: 1.02–1.10, P = 0.006), and baseline UA levels (OR = 1.01, 95% CI: 1.01–1.02, P < 0.001) as significant predictors. The nomogram demonstrated excellent discriminative ability (AUC = 0.85, 95% CI: 0.82–0.86) and calibration. In the validation cohort, persistent HUA was observed in 35.5% (89/251), and the nomogram maintained robust predictive performance (AUC = 0.81, 95% CI: 0.76–0.82). Conclusion Male sex, increased WC, and elevated baseline UA predict postoperative persistent HUA. The nomogram provides a practical clinical tool for predicting short-term HUA non-remission post-LSG.
- 3 March 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (4) , 1543-1546
Short-Term Outcomes of 400-cm Common Limb SADI-S in Chinese Patients with Obesity of BMI < 35 kg/m2 and Type 2 Diabetes
The aim of this study was to evaluate the short-term efficacy of single-anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S) using a 400-cm common limb in Chinese patients with obesity of low BMI (<35 kg/m²) and type 2 diabetes (T2D). Sixteen patients who underwent SADI-S between June 2022 and November 2023 were retrospectively analyzed and evaluated at 6 and 12 months postoperatively. The primary outcome was the rate of diabetes remission (HbA1c < 6.5% without antidiabetic medications for ≥ 3 months). Secondary outcomes included excess and total weight loss (EWL and TWL) and nutritional deficiencies. At 12 months postoperatively, 80% of patients achieved diabetic remission, with mean HbA1c decreasing from 8.84 ± 1.55 to 5.93 ± 0.74%. Mean BMI decreased from 30.64 ± 2.29 to 22.91 ± 2.33 kg/m², and EWL and TWL reached 122.12% ± 44.43% and 25.01% ± 8.02%, respectively. Nutritional status remained stable with no cases of hypoalbuminemia and fewer iron and vitamin deficiencies. SADI-S with a 400-cm common limb was effective in achieving glycemic control and weight loss while reducing the risk of nutritional deficiencies in Chinese patients with obesity of low BMI and T2D.
- 3 March 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (4) , 1543-1546
Short-Term Outcomes of 400-cm Common Limb SADI-S in Chinese Patients with Obesity of BMI < 35 kg/m2 and Type 2 Diabetes
The aim of this study was to evaluate the short-term efficacy of single-anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S) using a 400-cm common limb in Chinese patients with obesity of low BMI (<35 kg/m²) and type 2 diabetes (T2D). Sixteen patients who underwent SADI-S between June 2022 and November 2023 were retrospectively analyzed and evaluated at 6 and 12 months postoperatively. The primary outcome was the rate of diabetes remission (HbA1c < 6.5% without antidiabetic medications for ≥ 3 months). Secondary outcomes included excess and total weight loss (EWL and TWL) and nutritional deficiencies. At 12 months postoperatively, 80% of patients achieved diabetic remission, with mean HbA1c decreasing from 8.84 ± 1.55 to 5.93 ± 0.74%. Mean BMI decreased from 30.64 ± 2.29 to 22.91 ± 2.33 kg/m², and EWL and TWL reached 122.12% ± 44.43% and 25.01% ± 8.02%, respectively. Nutritional status remained stable with no cases of hypoalbuminemia and fewer iron and vitamin deficiencies. SADI-S with a 400-cm common limb was effective in achieving glycemic control and weight loss while reducing the risk of nutritional deficiencies in Chinese patients with obesity of low BMI and T2D.